Chokri Ben Lamine: A Two-Day Journey Through Modern Hematology at KFSHRC
Chokri Ben Lamine, Hematologist at King Faisal Specialist Hospital and Research Center, shared a post on LinkedIn:
”Advancing Hematology Through Shared Expertise | KFSHRC Center of Excellence Clinical Hematology Meeting
King Faisal Specialist Hospital and Research Centre, Riyadh
KACOLD, Level 1 — Executive Meeting Room
30 September–1 October 2026
The KFSHRC Center of Excellence in CLL preceptorship brings together a comprehensive two-day program covering CLL, leukemia, lymphoma, myeloma and cellular therapy—with practical discussions connecting clinical evidence to everyday patient care.
Opening sessions
Feras Alfraih delivers the welcome address, followed by Hazzaa Alzahrani’s overview of KFSHRC and the Cancer Centre of Excellence.
Day 1 | CLL and Leukemia
Infection prevention, vaccination and antimicrobial prophylaxis in the era of novel agents — Maha Alamri
CLL diagnosis and prognostic markers — Mohamed Masoud
Treatment-naïve CLL — Omar Albanyan
Relapsed/refractory CLL and subsequent treatment lines — Marwan Shaheen
CLL case discussions and real-world challenges — Naeem Chaudhri
Future directions in CLL management, including ASH/EHA developments — Mansour Alfayez
Clinical vignettes in mantle cell lymphoma — Waleed Rasheed
How I treat ALL in 2026 — Amr Hanbali
Day 2 | Lymphoma, Myeloma and Cellular Therapy
Antibody–drug conjugates, T-cell engagers and CAR-T in ALL — Hanan Alkhaldi
DLBCL diagnosis and prognostic markers — Dr. Khalid Alghamdi
How I treat DLBCL in 2026 — Alfadel Alshaibani
Richter transformation — Ahmed Alnughmush
T-cell engagers versus CAR-T in DLBCL — Abdulwahab Albabtain
CAR-T clinical evidence and the KFSHRC experience — Syed Osman
Recognizing and managing CLL drug toxicities — Hadeel Samarkandi
The clinical research model at KFSHRC — Riad Elfakih
Multiple myeloma: novel agents and the role of CAR-T — Abdullah Alamer
Beyond the lectures, the program includes a hospital tour spanning clinical care, research, pathology, data services and innovation, alongside networking and interactive discussion.
An opportunity to exchange experience, discuss challenging cases and strengthen collaboration in hematologic cancer care.
Appreciation to the organizers and faculty for sharing their expertise.”

Other posts featuring Chokri Ben Lamine on Hemostasis Today.
-
Nov 8, 2026, 15:0310 Posts Not to Miss This Week
-
Nov 8, 2026, 14:55Andra T.: Antiphospholipid Syndrome and Its Thrombotic Risks
-
Nov 8, 2026, 14:06Shayan Mohammadmoradi: ZEUS Trial-Inflammation Reduction Without Fewer Cardiovascular Events
-
Nov 8, 2026, 14:05Kausik Ray: Plaque-Guided Care for Better Coronary Outcomes
-
Nov 8, 2026, 14:05Athira Elssa Johnson: Understanding Coronary Thrombosis and Its Risks
-
Nov 8, 2026, 14:04Sanjiv Beri: Blood Type Compatibility and the Balance of Giving and Receiving
-
Nov 8, 2026, 14:02Gabriela Hobbs: Recognizing Outstanding Abstract Achievements-ASH 2026
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics